





The positive impact of influenza vaccination on
the prevention of hospital admission and death due
to respiratory diseases has been observed in many
areas throughout the world. It is estimated that, in
persons older than 65 years, vaccination can reduce
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Even though influenza vaccination is free and widely available in Brazil since 1999,
coverage is still inadequate in several of the country’s municipalities. The aim of the
present study was to estimate vaccine coverage and to identify factors related to
vaccination against influenza in the elderly population.
Methods
A household survey was carried out using a systematic random sample (N=365) of
the urban population older than 60 years from the city of Botucatu, Southeastern
Brazil. A logistic regression model using vaccination in 2002 as the dependent variable
was used. The following covariables were tested: sex, age, socioeconomic variables
(per capita income, number of persons per dormitory, schooling, marital status,
occupation, time living in the city), history of morbidity and hospital admission,
smoking, respiratory symptoms in last 15 days, and community activities (voluntary
work, neighborhood and church activities).
Results
Vaccine coverage was 63.2% (95% CI: 58.3-68.2). We found a lower proportion of
vaccination among the 60-64 years age group. Variables associated with vaccination
in the final model were age (OR=1.09 per year; 95% CI: 1.06-1.13); arterial
hypertension (OR=1.92; 95% CI: 1.18-3.13); and participation in community activities
(OR=1.63; 95% CI: 1.01-2.65). With the exception of hypertension, vaccination
among subjects with chronic diseases did not reach adequate levels, as expected for
this high-risk group. Participation in social and community activities was associated
with vaccination status.
Conclusions
Socioeconomic conditions, habits, and age did not restrict access to vaccination
campaigns. On the other hand, specific campaigns aimed at the 60-64 years age
group may increase vaccination coverage.
hospital admissions and mortality due to complica-
tions of respiratory diseases by 40-70%.8,13
Although influenza vaccination for elderly persons
is free and available in Brazil since 1999, coverage is
still unsatisfactory in several of the country’s munici-
palities. In the state of São Paulo, Southeastern Bra-
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Table 1 - Self-reported influenza vaccination among elderly subjects and age groups. Botucatu, Brazil, 2003.
Age group Population Vaccine coverage* 95% CI
(years) N %  (%)
60-64 93 25.5 40.9 35.8-45.9
65-69 84 23.1 61.9 56.9-66.9
70-74 81 22.2 67.9 63.1-72.7
75-79 53 14.6 84.9 81.2-88.6
≥80 53 14.6 75.5 75.5-79.9
Total 364 100.0 63.2 58.3-68.1
*Vaccination in 2002
Obs: one subject of unknown age χ2=34.95; Df=4; p<0.001
Table 2 - Respiratory symptoms and age group in elderly
subjects. Botucatu, Brazil, 2003.
Age group (years) Symptoms* % Total
60-64 9 9.7 93
65-69 14 16.7 84
70-74 15 18.5 81
75-79 8 15.1 53
≥80 9 17.0 53
Total 55 15.1 364
*Reported respiratory symptoms in last 15 days
Obs: one subject of unknown age χ2=3,18; Df=4; p=0,53
the 384 selected (5% loss). Field researchers were
trained and a pretest was conducted.
We analyzed the homogeneity of vaccine coverage
and respiratory symptoms in the different age groups
using the Chi-square test. We used bivariate analysis
to study the association between influenza vaccina-
tion in 2002 and covariables of interest, using odds
ratios and their respective confidence intervals as
estimates of association.15 Covariables showing p-
values below 0.20 were selected and tested using a
multiple logistic model, which included into the fi-
nal model variables with p-values below 0.05.
The present study was approved by the Research
Ethics Committee of the Faculdade de Medicina de
Botucatu/UNESP.
RESULTS
We found that 63.2% (95%CI: 58.3-68.2) of elderly
subjects reported vaccination in 2002. Table 1 presents
vaccine coverage in the different age groups. Subjects
aged 60-64 years showed the lowest coverage in the
period. Exploratory analysis showed that age distribu-
tion according to sex was similar in the sample and in
the population of the entire municipality.
Table 2 shows a similar distribution of respiratory
symptoms across the different age groups (χ2=3.18;
Df=4; p=0.53). Major symptoms are presented in Ta-
ble 3. Of the 55 subjects with flu-like symptoms in
the 15 days preceding the interview, 30 (54.6%) re-
ported more than one symptom, including coughing
and nose discharge (10 cases, 18.2%), coughing and
zil, 84% of the population older than 65 years was
vaccinated in 1999. From 2000 to 2003, coverage
among persons over 60 years was 63.9%, 66.6%,
65.6%, and 75%, respectively. Even without reach-
ing the expected levels, vaccine coverage increased
throughout the period. The vast majority of munici-
palities still show coverage levels below 80%.1
Investigations5,6,10,14 of the reasons for non-adher-
ence to vaccination have been proposed by health-
care technicians as subsidy for interventions aimed
at improving the current scenario and ensuring greater
protection to higher-risk populations.
Thus, the aim of the present study was to estimate
the coverage of vaccination and to analyze variables
related to influenza vaccination among persons over
age 60 years.
METHODS
We carried out a household survey using a system-
atic random sample (N=384) of the elderly population
of the urban area of Botucatu, a city of 130 thousand
inhabitants in the Center-West of the state of São Paulo.
Sample size was calculated assuming α=0.05; ß=0.2
(0.8 statistical power); and a prevalence of the studied
variables of 0.5. The sample was based on a registry of
9,000 families composed the year before data collec-
tion for a population-based study of work accidents
in the municipality.4 Criteria for inclusion of ran-
domly selected subjects into the study were as fol-
lows: age 60 years or older, living in Botucatu, being
found at home during one of the three attempted home
visits, not being institutionalized, and agreeing to
participate in the survey by providing written in-
formed consent. We collected information on sex, age,
per capita income, number of persons per dormitory,
schooling, time living in the city, marital status, oc-
cupation, history of morbidity and hospital admis-
sion in the previous year, history of vaccination in
the previous year, smoking, respiratory symptoms in
last 15 days, and social/community activities. Of the
total sample selected, five households were found
closed, three were summer houses, and 11 subjects
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chest mucus (7 cases, 12.7%), and sore throat and
malaise (5 cases, 9.1%).
Of the 365 subjects interviewed, 15.4% reported
diabetes, 7.4% lung conditions, 23.1% heart disease,
and 47.5% hypertension. With the exception of hy-
pertensive subjects, individuals with chronic diseases
showed vaccine coverage similar to those without
such conditions.
Socioeconomic variables (per capita income,
number of persons per dormitory, schooling) were not
associated with vaccination. However, the subject’s
insertion into the community (voluntary work, meet-
ings, neighborhood activities) was significantly as-
sociated with reported vaccination in 2002.
Table 4 shows the statistics obtained in bivariate
and multivariate analyses. Variables showing associa-
tion to reported vaccination were age (OR=1.09 for
each 1-year variation; 95CI%: 1.06-1.13); arterial hy-
pertension (OR=1.92; 95%CI: 1.18-3.13); insertion in
community activities (OR=1.63; 95%CI: 1.01-2.65).
DISCUSSION
The coverage of influenza vaccination detected in
2002 (63.2%; 95%CI: 58.3%-68.2%) was close to
that registered by the municipality’s Epidemiologi-
cal Surveillance System (ESS) - 58.3%.
We found a smaller percentage of vaccinated sub-
jects in the 60-64 years age group. Coverage in this
age group in our sample (40.9%; 95%CI: 35.8-45.9)
was even lower than that reported by the ESS (52.9%).
The probability of being vaccinated increases with
age according to a number of authors.5,14,16 This is
confirmed in the present analysis.
Reported respiratory symptoms in the 15 days pre-
ceding the interview was not associated with vacci-
nation in the final logistic model. A great variety of
etiological agents may be associated with viral respi-
ratory conditions. The most relevant virus types in-
clude respiratory syncytial viruses, parainfluenza vi-
ruses, rhinoviruses, and adenoviruses, among others.7,12
Thus, vaccination would not protect the population
against any airways infection, but only against cases
of influenza infection by viruses that are part of the
vaccine used in that season.2
Regarding specific symptoms, fever was rarely re-
ported by subjects, even in the presence of other more
frequent respiratory symptoms such as coughing, nose
discharge, and sore throat.
Although vaccination was self-reported rather than
documented, the sensitivity and specificity of self-
report have been considered high (0.98) and moder-
ate (0.71), respectively, in a study carried out among
elderly subjects.9
Table 3 - Respiratory symptoms in last 15 days reported by
elderly subjects. Botucatu, Brazil, 2003.
Symptom N (55) %
Nose discharge 23 41.8
Cough 19 34.6
Sore throat 15 27.3
Malaise 8 14.6





Table 4 - Statistics for the logistic model of association between influenza vaccination and covariables in the elderly
population. Botucatu, Brazil, 2003.
OR 95%CI p ORadj 95% CI p
Age* 1.09 1.05-1.13 0.00001 1.094 1.05-1.13 0.0001
Sex (male) 0.87 0.56-1.33 0.52
Schooling  (years)
< 2 1.13 0.66-1.91 0.67
2-7 1.08 0.64-1.81 0.78
8-11 1.81 0.70-4.68 0.22
>12 0.659 0.30-1.47 0.31
Per capita income 0.81 0.46-1.42 0.46
Other incomes 1.73 0.88-3.39 0.11
No. persons per dormitory 0.86 0.51-1.44 0.56
Alone** 1.68 1.06-2.66 0.02
Less than 10 years in town 1.76 0.18-17.01 0.63
Smoking 0.85 0.44-1.66 0.73
Hospital admiss./last year 0.86 0.40-1.85 0.71
Diabetes Mellitus 1.92 1.00-3.66 0.05
Hypertension 2.13 1.38-3.31 0.0007 1.92 1.18-3.13 0.008
Lung disease 1.18 0.51-2.71 0.69
Heart disease 1.62 0.95-2.75 0.08
Respiratory symptoms 1.51 0.77-2.97 0.26
Community activities 1.48 0.94-2.33 0.09 1.63 1.01-2.65 0.046
OR: Crude odds ratio in bivariate analysis; ORadj: Adjusted odds ratio in multiple logistic model.
*OR relative to variation for one year increase in age.
**Alone: without marital support, widow(er), single, separated.
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